We are thrilled to announce that Judo Bio has successfully raised $100 million in a significant funding round led by esteemed investors Atlas Venture and The Column Group. With this capital, Judo Bio is poised to accelerate its groundbreaking research and development efforts in the field of precision therapeutics. Operating in stealth mode, Judo Bio is on the cutting edge of innovation, focusing on a unique receptor targeting approach designed to create highly specific therapies. These precision therapeutics aim to address both common and rare genetic diseases, fulfilling significant unmet medical needs within the healthcare landscape. The ambitious funding will enable Judo Bio to expand its pipeline of innovative treatments and enhance its capabilities in targeting specific cell populations crucial to disease management. Our dedicated team, comprised of passionate scientific champions, is committed to discovering and developing transformative therapies that can improve the lives of patients and their families. As we enter this new phase of growth and development, we remain steadfast in our mission to leverage our innovative platform to catalyze change in the medical community and provide hope to those affected by genetic disorders. With the support of our investors and a talented team of experts, Judo Bio is excited to embark on a journey that promises to elevate the standard of care and lead to breakthroughs that could reshape treatment paradigms in the future.
Judo Bio Secures $100M in Series A Funding for Groundbreaking Precision Therapeutics Platform Development
Recently funded · $100.0M Series aBiotechnology Research
Get the full Judo Bio company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Qodia
Qodia, c’est plus de 25 ans d’expérience en automation et un savoir-faire reconnu pour la réalisation de machines complètes, le retrofit logiciel de machines existantes et le développement de cartes électroniques. Qodia, c’est aussi la conception d’un outil automation & HMI intuitif et évolutif : « X8 Automation Framework », pour lequel nous proposons une offre flexible : distribution sous-licence en direct de nos librairies PLC/HMI, support et accompagnement ou réalisation clé-en-main par nos équipes. Qodia has over 25 years of experience in automation systems and a recognized expertise in turnkey creation of machines, software retrofitting and the development of electronic boards. Qodia has also developed an intuitive and evolving automation & HMI tool: "X8 Automation Framework", for which we offer flexible solutions: direct sublicensing from our PLC/HMI libraries, support and guidance or turnkey realization by our teams.
$1.4M Seed
today
Lane
Lane is the world’s leading workplace experience platform. Founded in 2014 to transform and connect the workplace, our no-code enterprise software streamlines all aspects of day-to-day office life—from room bookings and access management, to communications and commerce, to events, data, and beyond. Our award-winning mobile and web technology is built to scale, allowing workplace providers to deploy globally and configure locally. Powering 300+ properties across 22 major cities in 8 countries, Lane clients include Brookfield, Oxford, Colliers, Dream, Nuveen, Studio by Tishman Speyer, and more. Putting all of the pieces together, Lane turns any workplace into a place that works. www.joinlane.com www.twitter.com/joinlane www.instagram.com/join_lane
Other recent Series a rounds
Companies that recently closed a Series a round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  AlgoriX Singapore | Series a | $11.5M | today |
| 2 |  Aligned Marketplace | Series a | $20.0M | today |
| 3 |
